featured
FDA Approval Summary: Palbociclib for Male Patients With Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
FDA Approval Summary: Palbociclib for Male Patients With Metastatic Breast Cancer
Clin. Cancer Res 2019 Oct 24;[EPub Ahead of Print], S Wedam, L Fashoyin-Aje, E Bloomquist, S Tang, R Sridhara, KB Goldberg, MR Theoret, L Amiri-Kordestani, R Pazdur, JA BeaverFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.